Nxera Pharma's Schizophrenia Treatment Enters Phase 3 Trials

TipRanksApr 30 19:52 ET

Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations

GlobeNewswireApr 30 19:05 ET

Kyowa Kirin, Mitsui & Co., Sumitomo Corp., Yamato HD (on the 1st).

※ The above Calendar is merely a schedule and may be subject to change due to the company's circumstances.--------------------------------------- May 1 (Thursday) <2148> ITM <2551> Marusan Ai <2579> Coca BJH <2768> Sojitz <299A> dely <3064> MonotaRO <4151> Kyowa Kirin <4206> Ai

Fisco JapanApr 30 17:30 ET

Kinden, Yamazaki Pan ETC (additional) Rating

Downgrade - Bearish Code Stock Name Securities Company Previous After--------------------------------------------------------------<6523> PHCHD Morgan Stanley "Equal Weight" "Under Weight" <8591> ORIX Morgan Stanley "Over Weight" "Equal Weight" Target Price Change Code Stock Name Securities Company Previous After------------------------------------

Fisco JapanApr 27 22:52 ET

Rating Information (Target Price Change - Part 1) = Kindan, Nexela, etc.

Nomura Securities (three-tier system: Buy > Neutral > Reduce) Kinden <1944.T> - "Buy" → "Buy", 4030 yen → 4260 yen Fujielectric <6504.T> - "Buy" → "Buy", 10200 yen → 9100 yen TDK <6762.T> - "Buy" → "Buy", 2450 yen → 2180 yen Keyence <6861.T> - "Buy" → "Buy", 79000 yen → 75000 yen Murata Manufacturing <6981.T> - "Buy" → "Buy"

Kabushiki ShimbunApr 27 20:56 ET

Aftermarket [Stocks that moved and stocks that were traded]

*Pasona <2168> 2155 +140 The cumulative operating profit and loss for the third quarter is a deficit of 1.28 billion yen, but the feeling of easing is dominant. *Needs Well <3992> 417 +61 A shareholder benefit system has been introduced. *Ecomott <3987> 444 +80 The operating profit for the first half is 0.044 billion yen. It turned from a deficit of 0.036 billion yen in the first quarter to a surplus. A share buyback with a limit of 2.85% of the issued stocks was also announced. *Flyer <323A> 703 +100 Evaluating the profit trends. The operating profit and loss is 24.

Fisco JapanApr 15 03:10 ET

Nxera Pharma Announces Appointments to Its Executive Leadership Team

GlobeNewswireApr 1 03:00 ET

List of cloud breakout stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud breakout stocks]

○ List of stocks breaking below the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <4538> Fuso Pharmaceutical 2442 2487.5 2491.5 <4565> Nexeller 9039 27.75997 <4662> Focus 1074 1091.751092 <4665> Duskin 3639 3710.753684 <4686> Just Systems 3370 3515

Fisco JapanMar 31 19:12 ET

Nxera Pharma: Interim report.

EDINETMar 26 03:38 ET · Announcements

Nxera Pharma: Confirmation

EDINETMar 26 03:36 ET · Announcements

Nxera Pharma: Financial Report - 35th Term (2024/01/01 - 2024/12/31)

EDINETMar 26 03:35 ET · Announcements

Nxera Pharma's Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment

TipRanksMar 25 17:27 ET

Nexcera, SBI Securities has reduced the Target Price to 1,500 yen.

On the 13th, SBI Securities maintained a "Buy" investment rating for Nextera Pharma <4565.T>. The Target Price has been reduced from 3000 yen to 1500 yen. A catalyst for an increase in valuation is considered essential. Provided by Wealth Advisor.

Kabushiki ShimbunMar 14 00:04 ET

F&LC, Denka, etc. (additional) Rating

Upgraded - Bullish Code Stock Name Securities Company Previous Change After----------------------------------------------------------------<6523> PHCHD Morgan S "Under W" "Equal W" <6869> Sysmex City "2" "1" <9020> JR East Nomura "Neutral" "Buy" Target Price Change Code Stock Name Securities Company Previous Change After----------------

Fisco JapanMar 12 23:20 ET

Jefferies Adjusts Nxera Pharma's Price Target to 2,000 Yen From 2,100 Yen, Keeps at Buy

MT NewswiresMar 12 05:47 ET · Ratings

List of conversion stocks (part 2) [List of stocks converting with Parabolic Signals]

○ List of stocks that have switched to Sell Market Code Stock Name Closing Price SAR Main Board ＜1719＞ Ando Hazama 1365 1385 ＜1812＞ Kashima 30723247 ＜1878＞ Daito Construction 1550016180 ＜2685＞ Adastria 29002975 ＜3064＞ MRO 24302659 ＜3349＞ Cosmos Pharmaceutical 70257365 ＜3475＞ Goodcom A 801835 ＜3593＞ Hogi

Fisco JapanMar 9 18:57 ET

Rating Information (Target Price Change - Part 1) = Matsukiyo Co., Pacific Cement, ETC.

◎Nomura Securities (three stages: Buy > neutral > Reduce) Matsukiyo <3088.T> -- "Buy" → "Buy", 3,400 yen → 3,500 yen JTEKT <6473.T> -- "Buy" → "Buy", 1,400 yen → 1,500 yen TOPPAN <7911.T> -- "Buy" → "Buy", 4,910 yen → 5,180 yen Dainippon Printing <7912.T> -- "Buy" → "Buy", 2,920 yen → 3,050 yen Unicharm <8113.T> -- "Buy".

Kabushiki ShimbunMar 3 19:52 ET

Nxera Pharma Assigns Japan and APAC (Ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris

GlobeNewswireFeb 27 19:05 ET

List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]

○ List of stocks for Buy conversion in the market Code Stock Name Final Price SAR Main Board <1419> Tamahome 3420 3270 <1780> Yamauchi 13101259 <2211> Fujiya 22812221 <2590> DyDo 29742883 <2692> Itochu Foods 75907350 <2734> Sara 808753 <2809> Kewpie 28472779 <3036> Howmet Aerospace Inc

Fisco JapanFeb 27 17:46 ET

Express News | [Change Report] Daisuke Gomi reported that the Shareholding percentage of Nexela Pharma (4565.JP) has increased to 9.5%.

Moomoo NewsFeb 26 02:47 ET